Glassman Wealth Services Ultragenyx Pharmaceutical Inc. Transaction History

Glassman Wealth Services

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	BUY	$45.8 - $85.4 $824 - $1,537	18 New	18 $1,000
Q2 2021 Aug 04, 2021	SELL	$92.19 - $115.71 $92 - $115	-1 Closed	0 $0
Q1 2021 May 05, 2021	BUY	$106.9 - $167.73 $106 - $167	1 New	1 $0
Q4 2019 Feb 07, 2020	SELL	$36.08 - $45.83 $216 - $274	-6 Closed	0 $0
Q1 2018 May 01, 2018	BUY	$44.33 - $58.52 $265 - $351	6 New	6 $0

326

85.7M

520K

406K

Ticker RARE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,036,896
Market Cap $3.01B
Description
Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...

Get notified when there are updates to the investment portfolio of Glassman Wealth Services, based on Form 13F filings with the SEC.

Stay updated on Glassman Wealth Services with notifications on news.